Stanford scientists turn a cancer driver into a kill switch
5 Articles
5 Articles
Stanford scientists turn a cancer driver into a kill switch
A Stanford-designed molecule turns a major lymphoma-promoting protein against cancer cells, activating their own self-destruct machinery instead of simply blocking tumor growth. In mice, the treatment completely eliminated aggressive human lymphoma tumors within 11 days, although much more testing is needed before it could reach patients.
Stanford scientists have succeeded in destroying tumors in 11 days by converting the BCL6 protein, which feeds on cancer, into a cell-killing trigger.
Stanford Medicine researchers have developed an experimental two-part molecule that turns one of the key mechanisms that leads to the development of lymphoma into a “weapon” against the cancer cells themselves. In experiments on mice, administering the molecule twice a day led to the complete disappearance of aggressive lymphoma tumors within 11 days. The […] The post Experimental new drug eliminates lymphoma tumors appeared first on iEidiseis.
Stanford Medicine researchers have made a breakthrough in the treatment of B-cell lymphoma: they have developed a new, two-part molecule that turns a key cancer-causing factor, the BCL6 protein, against the harmful cells. In tests on mice, the compound, TCIP3, eliminated aggressive lymphoma tumors in 11 days, while causing no toxic side effects.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
